Mamoura Diversified Global Holding PJSC, 10% Owner at RECURSION PHARMACEUTICALS, INC. (RXRX), bought 1,917,944 shares at $7.24 ($14.4M) on 2022-12-27, disclosed to the SEC on 2023-01-13.
Open-market purchase of $14.4M RXRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.52 | 100,378 | $755K | 5.2% |
| 2 | $7.52 | 100,378 | $755K | 5.2% |
| 3 | $7.24 | 145,652 | $1.1M | 7.3% |
| 4 | $7.24 | 145,652 | $1.1M | 7.3% |
| 5 | $7.18 | 71,299 | $512K | 3.6% |
| 6 | $7.18 | 71,299 |
| $512K |
| 3.6% |
| 7 | $7.71 | 84,622 | $652K | 4.5% |
| 8 | $7.71 | 84,622 | $652K | 4.5% |
| 9 | $7.55 | 99,754 | $753K | 5.2% |
| 10 | $7.55 | 99,754 | $753K | 5.2% |
| 11 | $7.50 | 141,646 | $1.1M | 7.4% |
| 12 | $7.80 | 91,892 | $717K | 5.0% |
| 13 | $7.80 | 91,892 | $717K | 5.0% |
| 14 | $7.38 | 80,035 | $591K | 4.1% |
| 15 | $7.38 | 80,035 | $591K | 4.1% |
| 16 | $7.41 | 68,953 | $511K | 3.6% |
| 17 | $7.41 | 68,953 | $511K | 3.6% |
| 18 | $7.64 | 76,046 | $581K | 4.0% |
| 19 | $7.64 | 76,046 | $581K | 4.0% |
| 20 | $7.72 | 69,518 | $537K | 3.7% |
| 21 | $7.72 | 69,518 | $537K | 3.7% |
| Total | $7.50 avg | 1,917,944 | $14.4M | 100% |
| Filing → |
| RXRX | BUY | 2023-02-22 | $1.5M | — | Filing → |
| RXRX | BUY | 2023-02-17 | $674K | — | Filing → |
| RXRX | BUY | 2023-02-15 | $50K | — | Filing → |